HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
Clinical trial NCT03850366 · RECRUITING
Trial details
- NCT number
- NCT03850366
- Sponsor
- Henry Ford Health System
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-08
- Primary completion
- 2028-01-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.